Metabolic Weekly
Research

OASIS Trials Unveil Game-Changing High-Dose Oral Semaglutide Results

The landscape of obesity treatment is undergoing a seismic shift, with recent data from the OASIS trials heralding a new era of oral options. Specifically, the OASIS 4 trial showcased that once-daily high-dose oral semaglutide demonstrated significant weight loss and improved metabolic markers, offering a convenient and effective alternative to injectables. This breakthrough could revolutionize patient access and adherence, making advanced obesity management more accessible than ever before. Discover how these pivotal findings are set to reshape clinical practice and patient outcomes.

Priya Mehra

Priya Mehra

Medical Science Writer

Dr. Yara Benedetti

Medically Reviewed by

Dr. Yara Benedetti

Endocrinologist, Johns Hopkins

Published March 18, 2026 · 7 min read

Explore Oral Semaglutide Options for Weight Management

Considering the latest advancements in obesity treatment? Remedy Meds connects you with healthcare providers who can assess if oral semaglutide is right for your weight management journey, offering personalized care and convenient access.

Find Your Treatment Plan →

The landscape of obesity treatment is undergoing a seismic shift, with the recent data from the OASIS trials heralding a new era of oral options. Specifically, the OASIS 4 trial showcased that once-daily oral semaglutide 25 mg delivered a remarkable 16.6% mean weight loss at 64 weeks in adults with obesity or overweight with comorbidities, compared to just 2.7% with placebo, as published in The New England Journal of Medicine in September 2024 and highlighted by

Related

Ready to Start Your GLP-1 Journey?

Connect with a licensed provider who can prescribe compounded semaglutide — starting at a fraction of brand-name cost.

Check Your Eligibility →

*Affiliate link. We may earn a commission at no extra cost to you.

Priya Mehra

Priya Mehra

Medical Science Writer

Health journalist covering GLP-1 medications, metabolic health, and the telehealth industry. All articles are fact-checked and medically reviewed.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare provider before starting any medication. Last updated: March 18, 2026.